U.S. Markets close in 5 hrs 2 mins

Esperion Therapeutics Inc (ESPR) President & CEO Timothy M Mayleben Bought $243,650 of Shares

- By insider

President & CEO of Esperion Therapeutics Inc (ESPR) Timothy M Mayleben bought 5,000 shares of ESPR on 03/14/2019 at an average price of $48.73 a share. The total cost of this purchase was $243,650.

Esperion Therapeutics Inc is a pharmaceutical company focused on developing and commercializing oral, low-density lipoprotein cholesterol, or LDL-C, lowering therapies for the treatment of patients with elevated LDL-C. Esperion Therapeutics Inc has a market cap of $1.32 billion; its shares were traded at around $49.03 . Esperion Therapeutics Inc had annual average EBITDA growth of 8.90% over the past ten years.


CEO Recent Trades:

  • President & CEO Timothy M Mayleben bought 5,000 shares of ESPR stock on 03/14/2019 at the average price of $48.73. The price of the stock has increased by 0.62% since.

Directors and Officers Recent Trades:

  • Director Roger S Newton sold 25,000 shares of ESPR stock on 03/12/2019 at the average price of $50.06. The price of the stock has decreased by 2.06% since.

For the complete insider trading history of ESPR, click here

.This article first appeared on GuruFocus.